{"id":"W2036143910","doi":"10.1158/1535-7163.targ-13-pr09","title":"Abstract PR09: Synergistic activity of CRLX101, a nanopharmaceutical in Phase II clinical trials, with antiangiogenic therapies mediated through HIF-1alpha inhibition: A translational research program.","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cancer research; Bevacizumab; Camptothecin; Angiogenesis; Metastasis; Cancer; Ovarian cancer; Tumor hypoxia; Gemcitabine; Oncology; Pharmacology; Internal medicine; Chemotherapy; Biology; Radiation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001588456,0.0009313559,0.0007752414,0.0004995969,0.0003011916,0.0008689261,0.001056921,0.001320619,0.004691409],"category_scores_gemma":[0.0005500981,0.0002966546,0.0007450837,0.0003713385,0.0005695104,0.0006827413,0.000371816,0.00224242,0.0009320253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007063535,"about_ca_system_score_gemma":0.001338055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007623484,"about_ca_topic_score_gemma":0.00181771,"domain_scores_codex":[0.9995976,0.0001566327,0.00003196835,0.00006813347,0.00007318974,0.00007259103],"domain_scores_gemma":[0.9995362,0.00007424606,0.000099049,0.00003527574,0.00005335395,0.0002019189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1180295,0.06583082,0.003727607,0.001906374,0.0009894711,0.0007410266,0.0002665887,0.003023217,0.5365533,0.001397122,0.01039689,0.2571379],"study_design_scores_gemma":[0.1569041,0.6412206,0.01382971,0.0001171661,0.0007855757,0.001589897,0.0001069739,0.00327854,0.1645971,0.0002925683,0.01721389,0.00006395105],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663689,0.0102588,0.005014426,0.002576724,0.0004044197,0.00606343,0.002327337,0.0005213499,0.006464534],"genre_scores_gemma":[0.9714225,0.005110904,0.008803413,0.001468678,0.0002058078,0.002361277,0.004160376,0.000067103,0.006400067],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004691409,"threshold_uncertainty_score":0.01569438,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1639044074039281,"score_gpt":0.4720174431728413,"score_spread":0.3081130357689132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}